S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ACRX AcelRX Pharmaceuticals Inc

0.86

0.00 (0.00%)

Apr 30 2024 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more AcelRX Pharmaceuticals Charts.

AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more AcelRX Pharmaceuticals Charts.

Acelrx Pharmaceuticals Inc News

Form ARS - Annual Report to Security Holders
Monday 29 April 2024 (2 days ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 29 April 2024 (2 days ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 29 April 2024 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 19 April 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 15 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 9 January 2024 (4 months ago) • Edgar (US Regulatory)

AcelRx Announces Rebranding With Name Change to Talphera, Inc.
Tuesday 9 January 2024 (4 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 December 2023 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 December 2023 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 December 2023 (5 months ago) • Edgar (US Regulatory)

More Acelrx Pharmaceuticals Inc News Articles

Global Developments (PK)

FBEC Worldwide (PK)

Mullen Automotive

Atacama Resources (PK)

NaturalShrimp (QB)

NioCorp Developments

Branded Legacy (PK)

Fannie Mae (QB)

MicroCloud Hologram

International Star (PK)

Tonner One World (PK)

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions